Equities

Pressure Biosciences Inc

PBIO:QBB

Pressure Biosciences Inc

Actions
  • Price (USD)0.14
  • Today's Change0.020 / 17.06%
  • Shares traded66.17k
  • 1 Year change-76.67%
  • Beta-0.2677
Data delayed at least 15 minutes, as of Jul 05 2024 17:16 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pressure BioSciences, Inc. is engaged in the development and sale of enabling, high pressure technology-based instruments, consumables, and services for the life sciences and other industries worldwide. Its products/services are based on three high-pressure platforms: Ultra Shear Technology (UST), BaroFold Technology (BaroFold), and Pressure Cycling Technology (PCT). The UST platform allows for the creation of stable nanoemulsions of otherwise immiscible oil-based active components in water. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. PCT utilizes alternating cycles of pressure to control biomolecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. The BaroFold platform provides valuable contract services and GMP manufacturing equipment to the biopharmaceutical industry.

  • Revenue in USD (TTM)1.98m
  • Net income in USD-35.20m
  • Incorporated1978
  • Employees15.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
PBIO:QBB since
announced
Transaction
value
CBH International LLCAnnounced11 Jan 202411 Jan 2024Announced-72.00%--
Data delayed at least 15 minutes, as of Jul 05 2024 17:16 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Applied DNA Sciences Inc5.52m-12.50m3.97m53.00------0.7191-17.13-17.137.67-0.05580.389310.384.64104,110.80-87.15-88.57-111.09-121.9133.9844.35-223.89-113.261.54-------26.4327.92-18.73--33.80--
Predictive Oncology Inc1.96m-14.78m3.97m34.00--0.9702--2.03-3.66-3.660.48530.99770.10991.714.9557,642.65-82.89-91.80-108.54-126.2964.1864.64-754.19-1,419.991.35--0.0093--18.244.7545.67--5.44--
Venus Concept Inc73.30m-37.39m4.01m304.00------0.0548-6.69-6.6913.12-3.540.74091.062.21241,125.00-37.61-32.71-56.83-44.0168.3768.16-50.77-48.501.35-3.441.40---23.2628.3114.76---35.08--
Sharps Technology Inc0.00-8.71m4.04m3.00--0.5893-----0.6204-0.62040.000.43780.00-------74.67---95.84----------0.492--0.00-------112.12------
Therapeutic Solutions International Inc97.68k-2.18m4.13m3.00--2.70--42.31-0.0006-0.00060.000030.00030.02571.305.4432,560.00-63.47-162.32-172.17--63.3667.79-2,468.37-2,391.850.4652-6.420.2868---52.1395.3543.11------
Reflect Scientific Inc1.27m-343.17k4.28m7.00--2.30--3.38-0.004-0.0040.01480.02170.51290.61845.72181,111.40-13.8811.10-16.4313.2156.0662.48-27.0710.002.21--0.00---47.09-6.99-613.46------
Hawkeye Systems Inc0.00-804.18k4.33m44.00---------0.1186-0.11860.00-0.290.00-------66.07-330.11-----------218.49---2.7810.45------4.85------
Arch Therapeutics Inc130.55k-8.43m4.40m8.00------33.70-3.68-3.680.0425-2.450.08330.0637--16,318.75-538.25-188.28---804.6333.37---6,458.14-26,945.920.0164-1.27----383.83---32.35---21.76--
Dror Ortho-Design Inc0.00-4.83m4.46m4.00--1.87-----0.0115-0.01150.000.00480.00-------357.10-140.50-595.21---------118,188.00----0.00-------1,896.02------
ADM Tronics Unlimited Inc2.85m-716.86k4.50m7.00--4.08--1.58-0.0106-0.01060.04210.01630.97723.854.25---24.62-11.45-38.81-15.7738.4543.73-25.19-15.281.24--0.2902--14.66-0.415993.04------
Nu-Med Plus Inc0.00-119.16k4.69m2.00---------0.0014-0.00140.00-0.0020.00----0.00-350.01-447.69---------------22.74--------3.56------
ReShape Lifesciences Inc8.34m-10.92m4.84m31.00--1.07--0.5803-2.30-2.300.73190.19330.67810.81784.52268,871.00-88.83-136.06-162.20-194.3265.8556.30-130.99-408.361.26--0.00---22.79-0.947475.36---49.29--
Pressure Biosciences Inc1.98m-35.20m4.86m15.00------2.46-1.65-1.650.0885-0.92611.292.388.86131,850.70-1,916.46-872.30----40.4332.33-1,482.20-1,066.480.0136-0.595----14.37-4.25-97.72------
Encision Inc6.87m-448.00k4.99m31.00--2.25--0.7263-0.0381-0.03810.58350.18631.641.967.84221,520.00-10.69-1.07-14.05-1.4650.5452.27-6.52-0.6131.08-6.220.1123---4.17-3.44-393.90--12.89--
Sonendo Inc40.19m-57.74m5.38m216.00--0.2194--0.1339-0.6125-0.55520.4260.34820.44482.077.58186,055.60-63.91---78.82--27.64---143.67--2.14-10.830.4695--5.30---6.78------
Bionoid Pharma Inc0.001.35m5.40m13.000.0882--3.99--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
Data as of Jul 05 2024. Currency figures normalised to Pressure Biosciences Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.